Mostrar el registro sencillo del ítem

Artículo

dc.creatorLópez Beas, Javieres
dc.creatorCapilla González, Vivianes
dc.creatorAguilera, Yolandaes
dc.creatorMellado, Nuriaes
dc.creatorLachaud, Christianes
dc.creatorMartín, Franzes
dc.creatorSmani Hajami, Tarikes
dc.creatorSoria Escoms, Bernates
dc.creatorHmadcha, Abdelkrimes
dc.date.accessioned2018-08-20T09:34:46Z
dc.date.available2018-08-20T09:34:46Z
dc.date.issued2018-09-07
dc.identifier.citationLópez Beas, J., Capilla-González, V., Aguilera, Y., Mellado, N., Lachaud, C., Martín, F.,...,Hmadcha, A. (2018). miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation. Molecular Therapy Nucleic Acids, 12, 463-477.
dc.identifier.issn2162-2531es
dc.identifier.urihttps://hdl.handle.net/11441/78182
dc.description.abstractHuman pluripotent stem cells retain the extraordinary capacity to differentiate into pancreatic beta cells. For this particular lineage, more effort is still required to stress the importance of developing an efficient, reproducible, easy, and cost-effective differentiation protocol to obtain more mature, homogeneous, and functional insulin-secreting cells. In addition, microRNAs (miRNAs) have emerged as a class of small non-coding RNAs that regulate many cellular processes, including pancreatic differentiation. Some miRNAs are known to be preferentially expressed in islets. Of note, miR-375 and miR-7 are two of the most abundant pancreatic miRNAs, and they are necessary for proper pancreatic islet development. Here we provide new insight into specific miRNAs involved in pancreatic differentiation. We found that miR-7 is differentially expressed during the differentiation of human embryonic stem cells (hESCs) into a beta cell-like phenotype and that its modulation plays an important role in generating mature pancreatic beta cells. This strategy may be exploited to optimize the potential for in vitro differentiation of hESCs into insulin-producing beta-like cells for use in preclinical studies and future clinical applications as well as the prospective uses of miRNAs to improve this process.es
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness BFU2016-74932-C2 BFU2013-45564-C2es
dc.description.sponsorshipFEDER Funds PI-0272-2017es
dc.description.sponsorshipAndalusian Regional Ministry of Health PI-0272-2017es
dc.description.sponsorshipEuropean Cooperation in Science and Technology BM1305es
dc.description.sponsorshipSpanish Ministry of Economy, Industry and Competitiveness CD16/00118es
dc.description.sponsorshipSpanish Institute of Health Carlos III PI16/00259 PI17/02104 RD16/0011/0034 CD16/00118es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherThe American Society of Gene and Cell Therapyes
dc.relation.ispartofMolecular Therapy Nucleic Acids, 12, 463-477.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjecthESCses
dc.subjectHS181es
dc.subjectDifferentiationes
dc.subjectBeta celles
dc.subjectMicroRNAes
dc.subjectmiR7es
dc.subjectInsulines
dc.subjectEndodermes
dc.subjectMaturationes
dc.subjectPluripotentes
dc.subjectPdx-1es
dc.subjectGene Ontologyes
dc.subjectKEGGes
dc.titlemiR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturationes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationCentro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)es
dc.contributor.affiliationInstituto de Biomedicina de Sevilla (IBIS)es
dc.relation.projectIDBFU2016-74932-C2es
dc.relation.projectIDBFU2013-45564-C2es
dc.relation.projectIDPI-0272-2017es
dc.relation.projectIDBM1305es
dc.relation.projectIDCD16/00118es
dc.relation.projectIDPI16/00259es
dc.relation.projectIDPI17/02104es
dc.relation.projectIDRD16/0011/0034es
dc.relation.projectIDCD16/00118es
dc.relation.publisherversionhttps://doi.org/10.1016/j.omtn.2018.06.002es
dc.identifier.doi10.1016/j.omtn.2018.06.002es
idus.format.extent15 p.es
dc.journaltitleMolecular Therapy Nucleic Acidses
dc.publication.volumen12es
dc.publication.initialPage463es
dc.publication.endPage477es

FicherosTamañoFormatoVerDescripción
miR-7 modulates hESC.pdf3.463MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional